0001183740-18-000089.txt : 20180503 0001183740-18-000089.hdr.sgml : 20180503 20180503155018 ACCESSION NUMBER: 0001183740-18-000089 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180503 DATE AS OF CHANGE: 20180503 EFFECTIVENESS DATE: 20180503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-311620 FILM NUMBER: 18803594 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 D 1 primary_doc.xml X0708 D LIVE 0001374339 ProMIS Neurosciences Inc. SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 415-341-5783 CANADA (FEDERAL LEVEL) AMORFIX LIFE SCIENCES LTD Corporation true Elliot Goldstein Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Eugene Williams Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director William Wyman Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Johannes Roth Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Patrick Kirwin Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Neil Cashman Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Richard Gregory Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Anthony Giovinazzo Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Daniel E. Geffken Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Johanne Kaplan Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Biotechnology Decline to Disclose 06b false 2018-04-19 true true true true true 5,783,861 Units at US$0.30 per Unit (comprised of one common share and one-half of one common share purchase warrant, exercisable into a share at C$0.48 until April 30, 2023, subject to acceleration) false 0 Noble Capital Markets, Inc. 15768 None None 225 NE Mizner Blvd, Suite 150 Boca Raton FL FLORIDA 33432 FL FLORIDA NV NEVADA NJ NEW JERSEY false 2845659 1735160 1110499 Offering Amount equals price of Units(5783861 x US$0.3(C$0.375)/unit) plus exercise price of underlying Warrants(2891926 x C$0.48(US$0.384)/share).No guarantee that the Warrants, expiring 4/30/2023, will be exercised. Based on exchange rate of US$1:C$1.25 false 18 64761 true 0 Placement fees of US$64,761 representing 7% of the gross proceeds from the sale of Units to investors introduced by Noble Capital Markets Inc., which also received 215,871 warrants, exercisable at C$0.48 per share for five years. 0 false ProMIS Neurosciences Inc. /s/ Elliot Goldstein Elliot Goldstein CEO and President 2018-05-03